A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity (Q41321490)

29 September 2017

1 reference

title

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity (English)

1 reference

29 September 2017

0 references

Pi-Sunyer FX

1

1 reference

PubMed ID

9001821

29 September 2017

language of work or name

1 reference

1 November 1996

1 reference

29 September 2017

Clinical Therapeutics

1 reference

29 September 2017

18

1 reference

29 September 2017

1006-35; discussion 1005

1 reference

29 September 2017

6

1 reference

Health implications of obesity.

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Short-term medical benefits and adverse effects of weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Proposed standards for judging the success of the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Long-term weight loss: the effect of pharmacologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Importance of weight loss and sodium restriction in the treatment of mild and moderate essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Weight reduction in the prevention and treatment of hypertension: a review of representative clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Weight reduction for control of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The effects of weight reduction on blood pressure in 301 obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Impact of gastric restrictive surgery on hypertension in the morbidly obese

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Benefits and adverse effects of weight loss. Observations from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Dietary therapy slows the return of hypertension after stopping prolonged medication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Weight reduction in a blood pressure clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Contrasting short- and long-term effects of weight loss on lipoprotein levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Reduction of atherogenic risk factors by short-term weight reduction. Evidence of the efficacy of National Cholesterol Education Program guidelines for the obese

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

A weight reduction intervention that optimizes use of practitioner's time, lowers glucose level, and raises HDL cholesterol level in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effectiveness of a low saturated fat, low cholesterol, weight-reducing diet for the control of hypertriglycer-idemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Long-term weight control study. VII (weeks 0 to 210). Serum lipid changes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Efficacy of dietary regulation in primary health care patients with hyperglycaemia detected by screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Drug treatment of obesity in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The Safety and Efficacy of a Controlled Low-Energy ('Very-Low-Calorie') Diet in the Treatment of Non-Insulin-Dependent Diabetes and Obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

A hypocaloric high-protein diet as primary therapy for adults with obesity-related diabetes: effective long-term use in a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Long-term effects of modest weight loss in type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Biliary Cholesterol Saturation and Weight Reduction – Effects of Fasting and Low Calorie Diet

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Weight, diet, and the risk of symptomatic gallstones in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Primary and secondary prevention of gallstone disease: implications for patient management and research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Alternative therapeutic approaches in sleep apnea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Prevention and management of gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Effect of weight-loss on plasma and urinary levels of uric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

The treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980057-9

7 January 2021

10.1016/S0149-2918(96)80057-9

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9001821